Coya Therapeutics (COYA) Revenue (2023 - 2026)
Coya Therapeutics (COYA) posted Revenue of $251147.0 for Q1 2026, down 93.66% sequentially from $4.0 million in Q4 2025, and down 2.61% YoY from $257884.0 in Q1 2025.
Coya Therapeutics (COYA) Revenue (2023 - 2026) Analysis & Trends
Coya Therapeutics has reported Revenue for 4 years, with the latest figure at $251147.0 in Q1 2026.
- Quarterly Revenue fell 2.61% year-over-year to $251147.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.9 million (up 115.44% YoY) and the FY2025 annual result came in at $7.9 million, up 123.57% from the prior year.
- Revenue eased to $251147.0 in Q1 2026 per COYA's latest filing, from $4.0 million in the prior quarter.
- Over five years, Revenue peaked at $6.0 million in Q4 2023 and troughed at $1952.0 in Q4 2024.
- A 4-year average of $2.0 million and a median of $257884.0 in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2024 and 2025: Revenue plunged 99.97% in 2024, then surged 202768.8% in 2025.
- Over 4 years, Revenue stood at $6.0 million in 2023, then slumped by 99.97% to $1952.0 in 2024, then soared by 202768.8% to $4.0 million in 2025, then slumped by 93.66% to $251147.0 in 2026.
- According to Business Quant data, Revenue over the past three periods registered $251147.0, $4.0 million, and $3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Coya Therapeutics | 113.30 Mn | 70.10 Mn | - | 243,745.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 243,745.00 |
| Mar 31, 2026 | 251,147.00 |
| Dec 31, 2025 | 3.96 Mn |
| Sep 30, 2025 | 3.56 Mn |
| Jun 30, 2025 | 163,616.00 |
| Mar 31, 2025 | 257,884.00 |
| Dec 31, 2024 | 1,952.00 |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 126,838.00 |
| Dec 31, 2023 | 6.00 Mn |